443 related articles for article (PubMed ID: 37501079)
1. Super-enhancers complexes zoom in transcription in cancer.
Wang M; Chen Q; Wang S; Xie H; Liu J; Huang R; Xiang Y; Jiang Y; Tian D; Bian E
J Exp Clin Cancer Res; 2023 Jul; 42(1):183. PubMed ID: 37501079
[TBL] [Abstract][Full Text] [Related]
2. The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors.
Li XP; Qu J; Teng XQ; Zhuang HH; Dai YH; Yang Z; Qu Q
Int J Biol Sci; 2023; 19(4):1036-1048. PubMed ID: 36923930
[TBL] [Abstract][Full Text] [Related]
3. The emerging role of super enhancer-derived noncoding RNAs in human cancer.
Wang Y; Nie H; He X; Liao Z; Zhou Y; Zhou J; Ou C
Theranostics; 2020; 10(24):11049-11062. PubMed ID: 33042269
[TBL] [Abstract][Full Text] [Related]
4. Super enhancer lncRNAs: a novel hallmark in cancer.
Song P; Han R; Yang F
Cell Commun Signal; 2024 Apr; 22(1):207. PubMed ID: 38566153
[TBL] [Abstract][Full Text] [Related]
5. Super-enhancers and novel therapeutic targets in colorectal cancer.
Liu Q; Guo L; Lou Z; Xiang X; Shao J
Cell Death Dis; 2022 Mar; 13(3):228. PubMed ID: 35277481
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms.
Jia Q; Chen S; Tan Y; Li Y; Tang F
Exp Mol Med; 2020 May; 52(5):713-723. PubMed ID: 32382065
[TBL] [Abstract][Full Text] [Related]
7. The super-enhancer repertoire in porcine liver.
Zhang Y; Zhang J; Wang C; Dai H; Du X; Li Q; Pan Z
J Anim Sci; 2023 Jan; 101():. PubMed ID: 36800318
[TBL] [Abstract][Full Text] [Related]
8. [Research progress of super enhancer in cancer].
Wu ZQ; Mi ZY
Yi Chuan; 2019 Jan; 41(1):41-51. PubMed ID: 30686784
[TBL] [Abstract][Full Text] [Related]
9. Super-enhancers: A new frontier for glioma treatment.
Cheng M; Zhang ZW; Ji XH; Xu Y; Bian E; Zhao B
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188353. PubMed ID: 32112817
[TBL] [Abstract][Full Text] [Related]
10. Multifaceted regulation of enhancers in cancer.
Xiao Q; Xiao Y; Li LY; Chen MK; Wu M
Biochim Biophys Acta Gene Regul Mech; 2022 Aug; 1865(6):194839. PubMed ID: 35750313
[TBL] [Abstract][Full Text] [Related]
11. Enhancer RNAs: a missing regulatory layer in gene transcription.
Mao R; Wu Y; Ming Y; Xu Y; Wang S; Chen X; Wang X; Fan Y
Sci China Life Sci; 2019 Jul; 62(7):905-912. PubMed ID: 30593613
[TBL] [Abstract][Full Text] [Related]
12. The molecular understanding of super-enhancer dysregulation in cancer.
Yoshino S; Suzuki HI
Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935
[TBL] [Abstract][Full Text] [Related]
13. Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers.
Hnisz D; Schuijers J; Lin CY; Weintraub AS; Abraham BJ; Lee TI; Bradner JE; Young RA
Mol Cell; 2015 Apr; 58(2):362-70. PubMed ID: 25801169
[TBL] [Abstract][Full Text] [Related]
14. Super-enhancers in cancer.
Thandapani P
Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
[TBL] [Abstract][Full Text] [Related]
15. Super-Enhancer-Driven Transcriptional Dependencies in Cancer.
Sengupta S; George RE
Trends Cancer; 2017 Apr; 3(4):269-281. PubMed ID: 28718439
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.
Chen Y; Ying Y; Ma W; Ma H; Shi L; Gao X; Jia M; Li M; Song X; Kong W; Chen W; Zheng X; Muluh TA; Wang X; Wang M; Shu XS
Cancer Res; 2024 Apr; 84(8):1237-1251. PubMed ID: 38241700
[TBL] [Abstract][Full Text] [Related]
17. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
[TBL] [Abstract][Full Text] [Related]
18. miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4.
Gen Y; Muramatsu T; Inoue J; Inazawa J
Cancer Res; 2021 Oct; 81(20):5190-5201. PubMed ID: 34353856
[TBL] [Abstract][Full Text] [Related]
19. Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies.
Dębek S; Juszczyński P
Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188697. PubMed ID: 35150791
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets.
Bacabac M; Xu W
Cancer Metastasis Rev; 2023 Jun; 42(2):471-480. PubMed ID: 37059907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
